Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AdaptHealth (AHCO) Invested Capital (2018 - 2025)

Historic Invested Capital for AdaptHealth (AHCO) over the last 8 years, with Q3 2025 value amounting to $3.4 billion.

  • AdaptHealth's Invested Capital fell 475.65% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 billion, marking a year-over-year decrease of 475.65%. This contributed to the annual value of $3.6 billion for FY2024, which is 153.16% down from last year.
  • According to the latest figures from Q3 2025, AdaptHealth's Invested Capital is $3.4 billion, which was down 475.65% from $3.4 billion recorded in Q2 2025.
  • AdaptHealth's 5-year Invested Capital high stood at $4.4 billion for Q1 2023, and its period low was $1.8 billion during Q1 2021.
  • Moreover, its 5-year median value for Invested Capital was $3.6 billion (2024), whereas its average is $3.3 billion.
  • As far as peak fluctuations go, AdaptHealth's Invested Capital surged by 211738.21% in 2021, and later plummeted by 1809.87% in 2024.
  • Over the past 5 years, AdaptHealth's Invested Capital (Quarter) stood at $4.3 billion in 2021, then increased by 1.77% to $4.3 billion in 2022, then dropped by 16.83% to $3.6 billion in 2023, then decreased by 1.53% to $3.6 billion in 2024, then decreased by 4.9% to $3.4 billion in 2025.
  • Its Invested Capital was $3.4 billion in Q3 2025, compared to $3.4 billion in Q2 2025 and $3.5 billion in Q1 2025.